Neuro-Ophthalmology

The Food and Drug Administration (FDA) has approved onabotulinumtoxin A for adult patients who suffer headaches on 15 or more days per month, lasting more than 4 hours. News, Medscape Medical News, October 2010

Maryland Center for Neuro-Ophthalmology and Neuro-Otology
Skip to toolbar